Companies spend more than $200 million over three years leading up to a launch and $10MM in internal headcount. Rising costs and industry pressures now require a more advanced commercialization model to ensure long-term commercial success and sustainable value for key stakeholders.
From industry-leading patient services and adherence solutions to global pricing and revenue management, EVERSANA’s end-to-end life sciences commercialization model increases speed to market and accelerates growth for pharmaceutical, medical device, and digital therapies.
EVERSANA’s comprehensive suite of commercial services powered by Data & Analytics help navigate product launches in this new era with confidence:
Imagine not having to risk building an expensive infrastructure – because we have built a foundation you can customize for your product needs. Activate a complete, ready-to-deploy, high-performance commercialization and distribution engine today!
Or use our solutions to optimize your launch and achieve your commercial goals
The intelligence you need to validate or inform your strategy across the product life cycle.
Learn MoreBreaking down the complexity of reimbursement and access. Engaging the Patient, Payer and Provider.
Learn MoreAssess your pricing and launch strategies globally. Answer the complex questions impacting your revenue.
Learn MoreAgile, all-inclusive supply chain model proven to maximize profits.
Learn MoreAutomated Processes Reduce Access Barriers & Simplify Onboarding
Learn MoreStrategies to support global launches and address complexities across markets.
Learn MoreMetrics Matter
Client Success Stories
Optimized the launch of a first-to-market orphan therapy with complex access and adherence challenges.
Learn MoreReduced access barriers and simplified patient onboarding for faster therapy initiation.
Learn More